Kraus, M.D., Stephen RSchool of Medicine |
|
|
Dr Kraus holds numerous appointments at the University of Texas Health Science Center at San Antonio. He is Professor and Vice Chairman of the Department of Urology where he heads the section of Female Urology, Neuro-Urology, and Voiding Dysfunction. In addition, Dr Kraus heads the Urology and Urodynamics Unit at the Spinal Cord Injury Center at the Audie Murphy VA Hospital and serves as medical director of the South Texas Pelvic Floor and Bladder Center, part of the University Hospital Urodynamics Laboratory and Incontinence Center. Dr Kraus was appointed President of the Governing Executive Board of the UTHSCSA Ambulatory Surgery Center at the MARC |
|
| 9/2009 - Present | Professor and Vice Chairman of Urology | University of Texas Health Science Center at San Antonio, Urology, San Antonio, TX |
| 6/2009 - Present | President, Governing Executive Board | UTHSCSA Ambulatory Surgery Center, San Antonio, TX |
| 7/2006 - Present | Fellowship Program Director | University of Texas Health Science Center at San Antonio, Urology, San ANtonio, TX |
| 11/2000 - Present | Attending Staff Urologist | Audie Murphy Veterans Administration Hospital, San Antonio, TX |
| 11/2000 - Present | Compliance Officer | University Physicians Group - Urology, San Antonio, TX |
| 11/2000 - Present | Director, Neuro-Urology & Urodynamics Training Program | Audie Murphy Veterans Administration Hospital, Urology, San Antonio, TX |
| 11/2000 - Present | Chief of Spinal Cord Urology | Audie Murphy Veterans Administration Hospital Spinal Cord and Urodynamics, Urology, San Antonio, TX |
| 11/2000 - Present | Medical Director | South Texas Pelvic Floor and Bladder Center, Urology, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 2008 | MS | Clinical Investigation | University of Texas Health Science Center San Antonio , TX |
| 1998 | Postdoctoral Fellowship | Neurourology and Urodynamics | Baylor College of Medicine, Scott Department of Urology Houston , TX |
| 1997 | Residency | Urology | U.M.D.N.J.-Robert Wood Johnson Medical School New Brunswick , NJ |
| 1993 | Internship | General Surgery | U.M.D.N.J.-Robert Wood Johnson Medical School New Brunswick , NJ |
| 1991 | MD | Medicine | U.M.D.N.J.-Robert Wood Johnson Medical School Piscataway , NJ |
| 1987 | BS | Biology | Brandeis University Waltham , MA |
Female Urology, Neuro-Urology & Voiding Dysfunctio |
| Date | Description | Institution | # Students |
| 7/2005 - Present | Instructor | UTHSCSA | 25 students |
| Urodynamics Conference-Multidisciplinary Resident & Fellow Educational Conference-weekly | |||
| 10/2004 - Present | Instructor | The University of Texas Health Science Center at San Antonio | |
| 2nd Year Medical Student Lectures & Instructor for Male Anatomy Labs. | |||
| 11/2000 - Present | Adv Clin Eval Skills | The University of Texas Health Science Center | |
| 3rd year medical students receive a lecture and watch a video of an actual male urologic physical exam. Students are then instructed with volunteer patients on the proper procedure for a digital rectal exam. | |||
Journal Article |
| Tomas L. Griebling, Stephen R. Kraus, Holly E. Richter, Dale B. Glasser, Martin Carlsson. Tolterodine Extended Release is Well Tolerated in Older Subjects International Journal of Clinical Practice 2009 Aug;63(8):1198-1204. |
| Amy M. Arisco, Elisa K. Brantly, Stephen R. Kraus. Oxybutynin extended release for the management of overactive bladder: a clinical review Drug Design, Development and Therapy 2009 May;2009(3):151-161. |
| Holly E. Richter, Kathryn L. Burgio, Toby C. Chai, Stephen R. Kraus, Yan Xu, Lee Nyberg and Linda Brubaker for the Urinary Incontinence Treatment Network. Predictors of outcomes in the treatment of urge urinary incontinence in women International Urogynecology Journal 2009 May;20(5):489-497. |
| Markland AD, Richter HE, Kenton K,Wai C, Nager CW, Kraus SR, Tennstedt SL, Xu Y For The UITN. Associated Factors and the Impact of Fecal Incontinence in Women with Urge Urinary Incontinence: From the Urinary Incontinence Treatment Networks BEDRI Study American Journal of Obstetrics and Gynecology 2009 Apr;200(4):424.e1-424.e8. |
| Linda Brubaker, Anne Stoddard,Holly Richter, Philippe Zimmern, Pamela Moalli, Stephen R. Kraus, Peggy Norton, Emily Lukacz,Larry Sirls, Harry Johnson for the Urinary Incontinence Treatment Network. Mixed Incontinence: Comparing Definitions in Women Having Stress Incontinence Surgery Neurourology and Urodynamics 2009 Apr;28(4):268-273. |
| Roger Dmochowski, Claus Roehrborn, Suzanne Klise, Lei Xu, Jed Kaminetsky and Stephen Kraus. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled 12 week clinical trial Journal of Urology (in press) 2009 Jan;. |
| Linda Brubaker, Pamela Moalli, Holly E. Richter, Michael Albo, Larry Sirls, Toby Chai, Stephen R. Kraus, Gary Lemack, Peggy Norton, Debuene Chang, and Sharon L. Tennstedt for the Urinary Incontinence Treatment Network. Challenges in Designing a Pragmatic Clinical Trial: The Mixed Incontinence Medical or Surgical Approach (MIMOSA) Trial Experience Journal of the Society for Clinical Trials (in press) 2009 Jan;. |
| Holly E. Richter, Kimberly Kenton, Liyuan Huang, Ingrid Nygaard, Stephen Kraus, Emily Whitcomb, Toby Chai, Gary Lemack, Larry Sirls, Kimberly Dandreo, Anne Stoddard. The Impact of Obesity on Urinary Incontinence Symptoms, Severity, Urodynamic Characteristics and Quality of Life Journal of Urology (in press) 2009 Jan;. |
| Charles W. Nager, Linda Brubaker, Firouz Daneshgari, Heather J. Litman, Kimberly J. Dandreo, Larry Sirls, Gary E. Lemack, Holly E. Richter, PhD, Wendy Leng, Peggy Norton, Stephen R. Kraus, Toby C. Chai, Debuene Chang, Cindy L. Amundsen, Anne M. Stoddard, and Sharon L. Tennstedt for the Urinary Incontinence Treatment Network. Design of the Value of Urodynamic Evaluation (ValUE) Trial: Contemporary Clinical Trials (in press) 2009 Jan;. |
| Stephen R. Kraus, Roger Dmochowski, Michael E. Albo, Lei Xu, Suzanne R. Klise, Claus G. Roehrborn. Urodynamic Standardization in a Large Scale, Multicenter Clinical Trial Examining the Effects of Daily Tadalafil in Men with Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia Neurourology and Urodynamics (in press) 2009 Jan;. |
| Tennstedt S, Litman H, Zimmern P, Ghetti C, Kusek J, Nager C, Mueller E, Kraus S, Varner E, Kraus, M.D. SR. Quality of life after surgery for stress incontinence Int Urogynecol J Pelvic Floor Dysfunct 2008 Dec;19(12):1631-1638. |
| Gary E. Lemack, Stephen Kraus, Heather Litman, Mary Pat FitzGerald, Toby Chai, Charles Nager, Larry Sirls, Halina Zyczynski, Jan Baker, Keith Lloyd and W. D. Steers for the Urinary Incontinence Treatment Network. Preoperative Urodynamic Testing Does Not PredictPostoperative Voiding Dysfunction Among Women Undergoing Surgery For SUI: Results From A Prospective Randomized Trial Comparing Burch Versus Pubovaginal Sling Journal of Urology 2008 Nov;180(5):2076-2080. |
| Claus G. Roehrborn, MD, Steven A. Kaplan, MD, Stephen R. Kraus, MD, FACS, Joseph T. Wang, MS, Tamara Bavendam, MD, Zhonghong Guan, MD, PhD. The Effects of Serum Prostate-Specific Antigen Level on the Efficacy of Tolterodine Extended Release with or without Tamsulosin in Men with Lower Urinary Tract Symptoms Including Overactive Bladder Urology 2008 Nov;72(5):1061-1067. |
| Kathryn L. Burgio,PhD, Stephen R. Kraus, MD, Shawn Menefee, MD, Diane Borello-France, PT, PhD, Marlene Corton, MD, Harry W. Johnson, MD, Veronica Mallett, MD, Peggy Norton, MD, Mary P. FitzGerald, MD, Kimberly J. Dandreo, MSc, Holly E. Richter, PhD, MD, Thomas Rozanski, MD, Michael Albo, MD, Halina M. Zyczynski, MD, Gary E. Lemack, MD, Toby C. Chai, MD, Salil Khandwala, MD, Jan Baker, APRN, Linda Brubaker, MD, Anne M. Stoddard, ScD, Patricia S. Goode, MD, Betsy Nielsen-Omeis, RN, BSN, Charles Nager, MD, Kimberly Kenton, MD, Sharon L. Tennstedt, PhD, John W. Kusek, PhD, T. debuene Chang, MD, Leroy M. Nyberg, MD, PhD, William Steers, MD, for the Urinary Incontinence Treatment Network*. Behavior Therapy to Enable Women with Urge Incontinence to Discontinue Drug Treatment Annals of Internal Medicine 2008 Aug;149(3):161-169. |
| Charles W. Nager, MaryPat FitzGerald, Stephen R. Kraus, Toby C. Chai, Halina Zyczynski, Larry Sirls, Gary E. Lemack, L. Keith Lloyd, Healther Littman, Anne M. Stoddard, Jan Baker, and William Steers for the Urinary Incontinence Treatment Network. Urodynamic Measures Do Not Predict Stress Continence Outcomes after Surgery for Stress Urinary Incontinence in Women Journal of Urology 2008 Apr;179(5):1470-1474. |
| Leslee L. Subak, Linda Brubaker, Toby C. Chai, Jennifer M. Creasman, Ananias C. Diokno, Patricia S. Goode, Stephen R. Kraus, John W. Kusek, Wendy Leng, Emily S. Lukacz, Peggy Norton, Sharon Tennstedt, for the Urinary Incontinence Treatment Network. High "costs" of urinary incontinence among women electing surgery to treat stress incontinence Obstetrics and Gynecology 2008 Apr;111(4):899-907. |
| Holly E. Richter, Ananias Diokno, Kimberly Kenton, Peggy Norton, Michael Albo, Stephen Kraus, Pamela Moalli, Toby C. Chai, Philippe Zimmern, Heather Litman and Sharon Tennstedt for the Urinary Incontinence Treatment Network. Predictors of Treatment Failure 24 Months After Surgery For Stress Urinary Incontinence Journal of Urology 2008 Mar;179(3):1024-1030. |
| Amy M. Arisco and Stephen R. Kraus. A Critical Review of Mesh Kits for Prolapse Repairs Current Bladder Dysfunction Reports 2008 Mar;3(1):19-25. |
| Markland AD, Gerety MB, Goode PS, Kraus SR, Cornell J, Hazuda HP, Kraus, M.D. SR. Urinary incontinence in community-dwelling older Mexican American and European American women Arch Gerontol Geriatr 2008 Feb;. |
| Urinary Incontinence Treatment Network. The Trial of Mid-Urethral Slings (TOMUS): Design and Methodology J Applied Res, 2008 Jan;8(1):1-13. |
| Steers, W, Richter, HE, Nyberg, L, Kusek, JW, Kraus, SR, Dandreo, KJ, Chai, TC, and Brubaker, L. Challenges of Conducting Multi-center, Multidisciplinary Urinary Incontinence Clinical Trials: Experience of the UITN Neurourology and Urodynamics (in press) 2008 Jan;. |
| Markland AD, Kraus SR, Richter HE, Nager CW, Kenton K, Kerr L, Xu Y for the Urinary Incontinence Treatment Network. Prevalence and Risk Factors of Fecal Incontinence in Women Undergoing Stress Incontinence Surgery Am J Obset Gynecology 2007 Dec;197(6). |
| FitzGerald M, Burgio K, Borello-France D, Memefee S, Schaffer J, Kraus S, Mallett V, Xu Y. for the Urinary Incontinence Treatment Network. Pelvic Floor Weakness is Associated with Fecal Incontinence and Overactive Bladder Physical Therapy 2007 Oct;87(10):1316-1324. |
| Amy A. Arisco and Stephen R. Kraus. Practice Point Commentary: Does intravesical atropine have equivalent efficacy to oral oxybutynin in the treatment of neurogenic detrusor overactivity? Nature Clinical Practice Urology 2007 Oct;4(10):538-539. |
| Arthur L. Burnett, Gunnar Aus, Edith D. Canby-Hagino, Michael S. Cookson, Anthony V. DAmico, Roger R. Dmochowski, David T. Eton, Jeffery D. Forman, S. Larry Goldenberg, Javier Hernendez, Celestia S. Higano, Stephen Kraus, Monica Liebert, Judd W. Moul, Catherine Tangen, J. Brantley Thrasher, Ian Thompson, and American Urological Association Prostate Cancer Guideline Update Panel. Erectile Function Outcomes Reporting After Clinically Localized Prostate Cancer Treatment The Journal of Urology 2007 Aug;178(2):597-601. |
| Stephen R. Kraus, Alayne Markland, Toby C. Chai, Anne Stoddard, Mary Pat FitzGerald, Wendy Leng, Veronica Mallett, Sharon L. Tennstedt, for the Urinary Incontinence Treatment Network. Race and ethnicity do not contibute to differences in preoperative urinary incontinence severity or symptom bother in women undergoing stress incontinence surgery American Journal of Obstetrics and Gynecology 2007 Jul;197(1):E1-E6. |
| Ian Thompson, M.D.,James Brantley Thrasher,M.D.,Gunnar Aus, M.D.,Arthur L. Burnett,M.D.,Edith D. Canby-Hagino,M.D.,Michael S. Cookson,M.D.,Anthony V. DAmico,M.D., PhD.,Roger R. Dmochowski,M.D.,David T. Eton,PhD.,Jeffrey D. Forman, M.D.,S.Larry Goldenberg,O.B.C.,M.D.,Javier Hernandez, M.D.,Celestia S. Higano,M.D.,Stephen R. Kraus,M.D.,Judd W. Moul, M.D.,Catherine M. Tangen,Dr. P.H. Guideline For The Management Of Clinically Localized Prostate Cancer: 2007 Update Journal of Urology 2007 Jun;. |
| Sharon L. Tennstedt, Mary Pat Fitzgerald, charles W. Nager, Yan Xu, Philippe Zimmern, Stephen Kraus, Patricia S. Goode, John W. Kusek, Diane Borello-France, Veronica Mallett. Quality of Life in Women with Stress Urinary Incontinence International Urogynecology Journal 2007 May;18(15):543-549. |
| Michael Albo,Lisa Wruck,Jan Baker,Linda Brubaker,Toby Chai,Kimberly J. Dandreo,Ananias Diokno,Patricia Goode,Stephen Kraus,John W. Kusek, Gary Lemack, Jerry Lowder, and William Steers. The Relationships Among Measures of Incontinence Severity in Women Undergoing Surgery for Stress Urinary Incontinence Journal of Urology 2007 May;177:1810-1814. |
| Michael Albo, Holly Richter, Linda Brubaker, Peggy Norton, Stephen R. Kraus, Philipe Zimmern, Toby Chai, Halina Zyczynski, Ananias Dionkno, Sharon Tenndstedt, Charles Nager, Keith Loyd, MaryPat FitzGerald, Gary E. Lemack, Harry W. Johnson, Weny Lengm, Veronica Mallet, Anne Stoddard, Shawn Menefee, Edward Varner, Kimberly Kenton, Pam Moalli, Larry Sirls, Kimberly Dandreo, John W. Kusek, Leroy Nyberg, and william Steers, for the Urinary Incontinence Treatment Network. Burch Colposuspension versus Fasical Sling to Reduce Urinary Stress Incontinence New England Journal of Medicine 2007 May;356:2143-2155. |
| Gary E. Lemack,Yan Xu,Linda Brubaker, Charles Nager,Toby Chai,Pamela Moalli,Stephen R. Kraus,Lindsey Kerr,Larry Sirls,Anne Stoddard, for the Urinary Incontinence Treatment Network. Clinical and Demographic factors Associated with Valsalva Leak Point Pressure Among Women Undergoing Burch Bladder Neck Suspension or Autologous Rectus Fascial Sling Procedures Neurourology and Urodynamics 2007 May;26(3):392-396. |
| C.W. Nager,M.E. Albo,M.P. Fitzgerald,S. McDermott,L. Wruck,S. Kraus,N. Howden,P. Norton,L. Sirls,E. Varner,P. Zimmern, for the Urinary Incontinence Traetment Network. Reference urodynamic Values for Stress Incontinent Women Neurology and Urodynamics 2007 May;26(3):333-340. |
| David O. Sussman,Stephen R. Kraus,Martin Carlsson,and Zhonghong Guan. Onset of Efficacy of Tolterodine Extended release in Patients with Overactive Bladder Current Medical Research and Opinion 2007 Apr;23(4):777-781. |
| Alayne D. Markland,Ian M. Thompson,Donna P. Ankerst,Betsy Higgins, and Stephen R. Kraus. Lack of Disparity in Lower Urinary Tract Symptoms Severity Between Community-Dwelling Non-Hispanic White, Mexican-American, and African-American Men Urology 2007 Apr;69:697-702. |
| Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, DAmico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations J Urol 2007 Feb;177(2):540-545. |
| Kraus S and the Urinary Incontinence Treatment Network. Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) Study Contemporary clinical Trials 2007 Jan;28(1):48-58. |
| Nager C,Albo M,Fitzgerald MP, McDermott S,Kraus S,Richter H,Zimmern P for the Urinary Incontinence Treatment Network. A Process for the Development of Multicenter Urodynamic Studies Urology 2007 Jan;69:63-67. |
| DAlton ME, Aronson P, Birnbach DJ, Bracken MB, Dawood MY, Henderson WG, Hughes B, Jobe AH, Katz VL, Kraus SR, Mangin M, matory JE, Moore TR, OCampo PJ, Peipert JF, Rothenberg KH, Stampfer MJ, Yonkers KA,. Cesarean Delivery on Maternal Request Obstetrics and Gynecology 2006 Jun;107(6):1386-1397. |
| Jeanette S. Brown, MD; Catherine S. Bradley, MD,MSCE; Leslee L. Subak, MD; Holley E. Richter, MD, PHD; Stephen R. Kraus, MD; Linda Brubaker, MD, MS; Feng Lin, MS; Eric Vittinghoff, PHD; and Deborah Grady, MD, MPH, for the Diagnostic Aspects of Incontinence Study (DAISY) Research Group. The Sensitivity and Specificity of a Simple Test to Distinguish between Urge and Stress Urinary Incontinence Annals of Internal Medicine 2006 May;144(10):715-723. |
| Subak LL, Brown JS, Kraus SR, Brubaker L, Lin F, Richter HE, Bradley CS, Grady D. The "costs" of urinary incontinence for women Obstet Gynecol 2006 Apr;107(4):908-916. |
| Albo M , Brubaker L, Chai T, Diokno A, Kraus S, Kusek J, Norton P, Nyberg L, Richter H, Steers W, Tennstedt S, Weber A, Zimmern P, Zyczynski H. Publications for the Urinary Incontinence Treatment Network (UITN): All publications for the UITN maintain the following authorship (listed by Principal Investigators in alphabetical order unless ranked otherwise as specified.). Design of the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr): A Randomized Surgical Trial Comparing the Burch Colposuspension and the Autologous Rectus Fascial Sling, The Urinary Incontinence Treatment Urology 2005 Dec;66:1213-1217. |
| Nalesnik J, Jones L and Kraus S,. Group B Streptococcal Septicemia following Intracavernosal injection Therapy for Erectile Dysfunction in Diabetes Journal of Urology 2004 Jul;172. |
Abstract |
| Dmochowski R, Roehrborn C, Kraus S, Xu L, Klise S. Changes in Bladder Outlet Obstruction Index in Men with signs and symptoms of Benign Prostatic Hyperplasia treated with Tadalafil; 2009 Apr. (Journal of Urology; vol. 181, no. 4). |
| Claus Roehrborn, Lei Xu, Roger Dmochowski, Stephen Kraus, Suzanne Klise. Reproducibility of Repeat Urodynamic Assessments From a Multicenter Trial in Men with Signs and Symptoms of Benign Prostatic Hyperplasia Following 12 Weeks of Placebo Treatment; 2009 Apr. (Journal of Urology; vol. 181, no. 4). |
| Kraus SR, Lemack G, Brubaker L, Chai T, Albo M, Litman M, Leng W, Sirls L, Lloyd LK, Norton P for the UITN. Urodynamic Changes Associated with Successful Stress Urinary Incontinence Surgery: A Little Tension is a Good Thing?; 2008 Apr. (Journal of Urology; vol. 179, no. 4). |
| Kraus SR, Lemack G, Chai T, Richter H, Albo M, Brubaker L, Sirls L, Litman H, Norton P, Leng W for the UITN. Urodynamic Changes 24 Months After Burch Colposuspension and Autologous Fascia Pubovaginal Sling; 2008 Apr. (Journal of Urology; vol. 179, no. 4). |
| Lemack G, Kraus SR, Chai T, Llyod K, Sirls L, Steers W, Stoddard A, Zyczynski H, Baker J, Fitzgerald MP, Nager C for the UITN. Preoperative Urodynamic Testing Does Not Predict Postoperative Voiding Dysfunction Among Women Undergoing Surgery For SUI: Results From A Prospective Randomized Trial Comparing Burch Versus Pubovaginal Sling; 2008 Apr. (Journal of Urology; vol. 179, no. 4). |
| Zimmern P, Tennstedt S, Kusek J, Mueller E, Nager C, Varner E, Ghetti C, Kraus SR. The Effect of Surgery for Stress Urinary Incontinence on Quality of Life in Women Enrolled in a Randomized Clinical Trial Comparing the Burch and Sling Procedures; 2008 Apr. (Journal of Urology; vol. 179, no. 4). |
| Michael Albo, Holly Richter, Linda Brubaker, Peggy Norton, Stephen R. Kraus, Philipe Zimmern, Toby Chai, Halina Zyczynski, Ananias Dionkno, Sharon Tenndstedt, Charles Nager, Keith Loyd, MaryPat FitzGerald, Gary E. Lemack, Harry W. Johnson, Weny Lengm, Veronica Mallet, Anne Stoddard, Shawn Menefee, Edward Varner, Kimberly Kenton, Pam Moalli, Larry Sirls, Kimberly Dandreo, John W. Kusek, Leroy Nyberg, and William Steers, for the Urinary Incontinence Treatment Network. Burch Colposuspension versus Fasical Sling to Reduce Urinary Stress Incontinence; 2007 Apr. (Journal of Urology; vol. 177, no. 4). |
| C.G.Roehrborn, S.A.Kaplan, S.R.Kraus, J.T.Wang, T.Bavendam and Z.Guan. Tolterodine extended release and/or Tamsulosin in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB): effects of serum prostate-specidic antigen (PSA) level; 2007 Jan. (Urology; vol. 70, no. 3). |
| Ananias Diokno, Holly E. Richter, Kimberly Kenton, Peggy Norton, Micheal Albo, Stephen Kraus, Pamela Moalli, Toby C. Chai, Philippe Zimmern,Heather Litman and Sharon Tennstedt for the Urinary Incontinence Treatment Network. Risk Factors Associated with Failure of Surgical Treatment Treatment for Stress Urinary Incontinence at 24 Months Follow-up; 2007 Jan. (Neurourology and Urodynamics; vol. 26, no. 5). |
| Charles W. Nager, Toby C. Chai, MaryPat FitzGerald, Gary E. Lemack, Stephen R. Kraus, Larry Sirls, Halina Zyczynski, L. Keith Lloyd, Jan Baker, Anne M. Stoddard, and William Steers for the Urinary Incontinence Treatment Network. Valsalva Leak Point Pressures and Detrusor Overactivity Do Not but Urodynamic Stress Incontinence Does Predict Continence Outcomes after Burch or Pubovaginal Sling Procedures; 2007 Jan. (Neurourology and Urodynamics; vol. 26, no. 5). |
| Tennstedt S, Fitzgerald M, Nager C, Xu Y, Zimmern P, Kraus S, Goode P, Kusek J, Borello-France D, Mallett V. for the Urinary Incontinence Treatment Network. Quality of Life in Women with Stress Urinary Incontinence; 2006 Oct. (International Journal of Urogynecology). |
| Kenton K. Brubaker L, FitzGerald MP, Creasman J, Bradley C, Kraus S, Brown J. "No Opinion": An Opinion of Many Incontinent Women; 2006 Oct. (International Urogynecology Journal; vol. 17, no. 3). |
| S. Kraus, H.E. Richter, D.B. Glasser, M. Carllsson. The Tolerability of Tolterodine is Not Diminished in Older Patients; 2006 Oct. (International Urogynecology Journal; vol. 17, no. 3). |
| S. Kraus, A.D. Markland, T.C. Chai. A.M. Stoddard, M.FitzGerald, W.W. Leng, V.T. Mallett, S. Tennstedt. Race/Ethnic Differences in Symptoms and Impacts of Urinary Incontinence In Women Undergoing Stress Incontinence Surgery; 2006 Oct. (International. Urogynecology Journal; vol. 17, no. 3). |
| Lemack G, Brubaker L, Nager C,Sirls C, Chai, T,Moalli P, Kraus S, Kerr S, Xu Y for the Urinary Incontinence Treatment Network. Demographic and Urodynamic Baseline Predictors of Valsalva Leak Point Pressure; 2006 May. (Journal of Urology; vol. 175, no. 4). |
| Markland A, Gerety M, Kraus S, Cornell J, Hazuda H. Ethnic Differences And Urinary Incontinence In Older, Community-Dwelling Mexican Americans And European Americans; 2005 Apr. (Journal of Urology). |
| Nager C, Albo M, Fitzgerald M P, Wruck L, McDermott S, Norton 4, Kraus S, Howden N, Sirls L, Varner E, Zimmern P, for the UITN. Non-Invasive Uroflowmetry And Filling Cystometry Values In A Large Cohort Of Women Undergoing Surgery For Pure Or Predominant Stress Urinary Incontinence; 2005 Jan. (Neurourology and Urodynamics; vol. 25, no. 5-6). |
| Tennstedt S, Borello-France D, Fitzgerald M, Goode P, Kraus S, Kusek J, Mallet V, Nager C, Stoddard A and Zimmern P for the UITN. Health Related Quality of Life in Women Before Surgical Treatment for Stress Urinary Incontinence; 2005 Jan. (Journal of Pelvic Medicine and Surgery; vol. 11, no. 1). |
| Suback L, Grady D, Wassel-Fyr C, Bradley C, Richter H, Kraus S, Brubaker L, and Brown J. The Costs of Urinary Incontinence; 2005 Jan. (Journal of Pelvic Medicine and Surgery; vol. 11, no. 1). |
| Fenton AS, Kraus SR, Marcovich R. Endourologic management of focal ileovesicostomy stenosis. Abstract MP 26/14; 2004 Nov. (J Endourol; vol. 18, no. Supp1). |
Editorial |
| Kraus SR. Editorial comment on Spiral Sling Procedure Journal of Urology 2006 May;175(5):1798-1799. |
Federal |
|
| Funding Agency | Southwest Oncology Group |
| Title | Protocol for Assessment of Gemcitabine and Paclitaxel for Metastatic Urothelial Cancer in patients Ages 70 Years or Older (And in a Cohort of Patients Younger than 60 Years) (012-5011-015) |
| Status | Active |
| Period | 12/2001 - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases |
| Title | Stress Incontinence Surgical Treatment Trial (UITN Protocol #1) (SISTER) |
| Status | Active |
| Period | 10/2001 - Present |
| Role | Principal Investigator |
| Grant Detail | Principal Investigator Co-Chairman, Protocol Subcommittee Steering Committee Core Member for UITN (with salary support) Publication and Presentation Committee Inclusion/Exclusion Criteria work group Pad Test, Diary, Quality of Life, Self-Efficacy, & Costs Work Group Complications and Adverse Events Committee $1,120,755 (adjusted for supplements & extension) Duration: 6 years (projected completion year 2007) |
| Funding Agency | National Cancer Institute, Early Detection Research Network |
| Title | Detection of Bladder cancer by Microsatellite Analysis (MSA) of Urinary Sediment: |
| Status | Active |
| Period | 3/2004 - Present |
| Role | Co-Investigator |
| Grant Detail | Multi-Institutional Study |
| Funding Agency | Southwest Oncology Group |
| Title | MVAC in Organ-Confined Bladder Cancer Based on p53 Status (012-5011-213) |
| Status | Active |
| Period | 4/2003 - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | National Institute of Diabetes and Digestive and Kidney Diseases |
| Title | The Urinary Incontinence Treatment Network |
| Status | Active |
| Period | 9/2006 - 6/2010 |
| Role | Principal Investigator |
| Grant Detail | Principal Investigator, Co-Chairman, BEDRI Protocol, Steering Committee Core Member(w/salary support) Vice-Chairman Publications & Presentations |
| Funding Agency | National Center on Minority Health & Health Disparities, National Institute of Health |
| Title | National Center on Minority Health & Health Disparities (NCMHD) LRP IV |
| Status | Active |
| Period | 9/2006 - 9/2008 |
| Role | Principal Investigator |
| Grant Detail | |
Private |
|
| Funding Agency | GSK |
| Title | A Randomized, Double-Blind, Parallel Group Study to Investigate the Efficacy and Safety of Treatment with Dutasteride (0.5mg) and Tamsulosin (0.4mg), Administered Once Daily for 4 Years, Alone and in Combination, on the Improvement of Symptoms and Clinic |
| Status | Active |
| Period | 8/2003 - Present |
| Role | Principal Investigator |
| Grant Detail | Closed to accrual 12/2004 |
| Funding Agency | Guilford Pharmaceuticals, Inc. |
| Title | Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 3 Arm, 12 Month Study to Evaluate the Effects of GPI 1485 on Erectile Function in Patients Undergoing Bilateral Nerve-Sparing Radical Retropubic Prostatectomy for Prostatic Carcinoma (0 |
| Status | Active |
| Period | 9/2003 - Present |
| Role | Co-Investigator |
| Grant Detail | Closed to accrual 03/2005 |
| Funding Agency | Merch & Co. Inc. |
| Title | Double-Blind Randomized, Placebo Controlled., Multicenter Study to Evaluate the Effect of Adjuvant Treatment with Rofecoib (MK-0966) in Localized Prostate Cancer |
| Status | Complete |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | Closed |
| Funding Agency | Pfizer |
| Title | Randomized Double Blind Placebo Controlled Four Arm Study (Placebo Tolterodine ER, Tamsulosin, and combination Tolterodine ER plus Tamsulosin) for the treatment of men with lower urinary track symptoms |
| Status | Complete |
| Period | 11/2004 - Present |
| Role | Principal Investigator |
| Grant Detail | Enrollment closed |
| Funding Agency | Lilly-ICOS |
| Title | Lilly-ICOS LVHK: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multicenter Study to Evaluate the Urodynamic Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia |
| Status | Active |
| Period | 2/2007 - Present |
| Role | Principal Investigator |
| Grant Detail | Award is based on competitive recruitment. Total dollar value represents awarded funds for 21 subjects recruited. Original recruitment goal of 7 subjects was surpassed in 3 months with IRB approval. |
| Funding Agency | National Cancer Institute/National Institute of Health |
| Title | San Antonio Center for Biomarker Research (SABOR) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |